Pfizer Inc.
Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same
Last updated:
Abstract:
The present disclosure generally relates to nanoparticles comprising an endo-lysosomal escape agent, a nucleic acid, and a polymer. Other aspects include methods of making and using such nanoparticles.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2021
Issue date:
26 Aug 2021